SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Boston Scientific (BSX) Any Comments??? -- Ignore unavailable to you. Want to Upgrade?

To: Y. Bob Ai who wrote (440)8/11/1998 8:29:00 PM
From: John Carragher  Read Replies (1) | Respond to of 798
 
September worth mag. stocks to avoid by Garic Moran "short seller" runs atlanta-based HawkeyePartners.

Boston Scientific fair value $40. Highly competitive coronary-stent business becoming commodity-like ..rising inventories and receivables.

Anybody got any comments esp as to inventories and receivables. John



To: Y. Bob Ai who wrote (440)8/11/1998 9:56:00 PM
From: Cynic 2005  Read Replies (1) | Respond to of 798
 
<<Working for FDA must be an easy job--just drinking coffee and chatting. >>
You got that right. They, at FDA, don't realize how the investors are missing out opportunity to make 10% during the time they drink a cup of coffee. What a bunch of jerks.
-g-
-MMV


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News